These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 21962403

  • 21. HIV-1/HAART-Related Lipodystrophy Syndrome (HALS) Is Associated with Decreased Circulating sTWEAK Levels.
    López-Dupla M, Maymó-Masip E, Martínez E, Domingo P, Leal M, Peraire J, Viladés C, Veloso S, Arnedo M, Ferrando-Martínez S, Beltrán-Debón R, Alba V, Gatell JM, Vendrell J, Vidal F, Chacón MR.
    PLoS One; 2015; 10(12):e0144789. PubMed ID: 26658801
    [Abstract] [Full Text] [Related]

  • 22. Low blood levels of sTWEAK are related to locoregional failure in head and neck cancer.
    Avilés-Jurado FX, Terra X, Gómez D, Flores JC, Raventós A, Maymó-Masip E, León X, Serrano-Gonzalvo V, Vendrell J, Figuerola E, Chacón MR.
    Eur Arch Otorhinolaryngol; 2015 Jul; 272(7):1733-41. PubMed ID: 24858806
    [Abstract] [Full Text] [Related]

  • 23. Mortality in patients with premature lower extremity atherosclerosis.
    Rana H, Andrews JS, Chacko BG, Hansen KJ, Levy PJ.
    J Vasc Surg; 2013 Jan; 57(1):28-35; discussion 35-6. PubMed ID: 23146425
    [Abstract] [Full Text] [Related]

  • 24. Soluble CD163 and TWEAK in early pregnancy gestational diabetes and later glucose intolerance.
    Dereke J, Nilsson J, Nilsson C, Strevens H, Landin-Olsson M, Hillman M.
    PLoS One; 2019 Jan; 14(5):e0216728. PubMed ID: 31071174
    [Abstract] [Full Text] [Related]

  • 25. Prevention of ischemic events in patients with peripheral arterial disease design, baseline characteristics and 2-year results an observational study.
    Blinc A, Kozak M, Sabovic M, Božic M, Stegnar M, Poredoš P, Kravos A, Barbic-Žagar B, Pohar Perme M, Stare J, PID-PAB Investigators.
    Int Angiol; 2011 Dec; 30(6):555-66. PubMed ID: 22233617
    [Abstract] [Full Text] [Related]

  • 26. The predictive role of sTWEAK levels in pregnant women with first-trimester vaginal bleeding.
    Kasap B, Özel Türkçü Ü, Akbaba E, Sarıyıldız B, Küçük M, Turhan NÖ, Öner G, Özcan A.
    J Matern Fetal Neonatal Med; 2018 Jul; 31(13):1715-1719. PubMed ID: 28462593
    [Abstract] [Full Text] [Related]

  • 27. Plasma Soluble CD163 Level Independently Predicts All-Cause Mortality in HIV-1-Infected Individuals.
    Knudsen TB, Ertner G, Petersen J, Møller HJ, Moestrup SK, Eugen-Olsen J, Kronborg G, Benfield T.
    J Infect Dis; 2016 Oct 15; 214(8):1198-204. PubMed ID: 27354366
    [Abstract] [Full Text] [Related]

  • 28. Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.
    Andersen MN, Abildgaard N, Maniecki MB, Møller HJ, Andersen NF.
    Eur J Haematol; 2014 Jul 15; 93(1):41-7. PubMed ID: 24612259
    [Abstract] [Full Text] [Related]

  • 29. Soluble TWEAK is markedly upregulated in patients with ST-elevation myocardial infarction and related to an adverse short-term outcome.
    Chorianopoulos E, Jarr K, Steen H, Giannitsis E, Frey N, Katus HA.
    Atherosclerosis; 2010 Jul 15; 211(1):322-6. PubMed ID: 20303491
    [Abstract] [Full Text] [Related]

  • 30. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
    Sigvant B, Kragsterman B, Falkenberg M, Hasvold P, Johansson S, Thuresson M, Nordanstig J.
    J Vasc Surg; 2016 Oct 15; 64(4):1009-1017.e3. PubMed ID: 27209402
    [Abstract] [Full Text] [Related]

  • 31. The impact of synbiotic on serum sCD163/sTWEAK, paraoxonase 1, and lipoproteins in patients with chronic heart failure: a randomized, triple-blind, controlled trial.
    Matin SS, Shidfar F, Naderi N, Amin A, Hosseini-Baharanchi FS, Dehnad A.
    Sci Rep; 2024 Aug 18; 14(1):19120. PubMed ID: 39155305
    [Abstract] [Full Text] [Related]

  • 32. Inter- not intraindividual differences in sTWEAK levels predict functional deterioration and mortality in patients with dilated cardiomyopathy.
    Jarr KU, Nelles M, Katus HA, Chorianopoulos E.
    Mediators Inflamm; 2014 Aug 18; 2014():576482. PubMed ID: 25089077
    [Abstract] [Full Text] [Related]

  • 33. Matrix metalloproteinase 10 is associated with disease severity and mortality in patients with peripheral arterial disease.
    Martinez-Aguilar E, Gomez-Rodriguez V, Orbe J, Rodriguez JA, Fernández-Alonso L, Roncal C, Páramo JA.
    J Vasc Surg; 2015 Feb 18; 61(2):428-35. PubMed ID: 25441671
    [Abstract] [Full Text] [Related]

  • 34. Diagnostic and prognostic significance of cell death and macrophage activation markers in patients with hepatocellular carcinoma.
    Waidmann O, Köberle V, Bettinger D, Trojan J, Zeuzem S, Schultheiß M, Kronenberger B, Piiper A.
    J Hepatol; 2013 Oct 18; 59(4):769-79. PubMed ID: 23792028
    [Abstract] [Full Text] [Related]

  • 35. The effect of acute kidney injury after revascularization on the development of chronic kidney disease and mortality in patients with chronic limb ischemia.
    Arora P, Davari-Farid S, Pourafkari L, Gupta A, Dosluoglu HH, Nader ND.
    J Vasc Surg; 2015 Mar 18; 61(3):720-7. PubMed ID: 25499712
    [Abstract] [Full Text] [Related]

  • 36. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH, Arpegård J, Ostergren J, Svensson P.
    Am J Hypertens; 2014 Mar 18; 27(3):363-71. PubMed ID: 24470529
    [Abstract] [Full Text] [Related]

  • 37. Additive effects of soluble TWEAK and inflammation on mortality in hemodialysis patients.
    Carrero JJ, Ortiz A, Qureshi AR, Martín-Ventura JL, Bárány P, Heimbürger O, Marrón B, Metry G, Snaedal S, Lindholm B, Egido J, Stenvinkel P, Blanco-Colio LM.
    Clin J Am Soc Nephrol; 2009 Jan 18; 4(1):110-8. PubMed ID: 18945991
    [Abstract] [Full Text] [Related]

  • 38. Serum changes in sTWEAK and its scavenger receptor sCD163 in ultramarathon athletes running the 24-h race.
    Benedetti S, Gemma Nasoni M, Palma F, Citarella R, Luchetti F.
    Cytokine; 2021 Jan 18; 137():155315. PubMed ID: 33011401
    [Abstract] [Full Text] [Related]

  • 39. Increased release of soluble CD163 by the peripheral blood mononuclear cells is associated with worse prognosis in patients with systemic sclerosis.
    Bielecki M, Kowal K, Lapinska A, Chyczewski L, Kowal-Bielecka O.
    Adv Med Sci; 2013 Jan 18; 58(1):126-33. PubMed ID: 23640944
    [Abstract] [Full Text] [Related]

  • 40. Soluble TWEAK and cardiovascular morbidity and mortality in chronic kidney disease patients.
    Hassan SB, El-demery AB, Ahmed AI, Abukhalil RE.
    Arab J Nephrol Transplant; 2012 Jan 18; 5(1):27-32. PubMed ID: 22283863
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.